On October 9, 2025, Sunflower Bank, N.A. disclosed in a regulatory filing that it sold 106,032 shares of Procter & Gamble (PG -1.44%) for approximately $16.56 million during the third quarter.What HappenedAccording to a filing with the Securities and Exchange Commission dated October 9, 2025, Sunflower Bank, N.A. reduced its stake in Procter & Gamble by 106,032 shares in Q3 2025. The estimated value of the shares sold was $16.56 million, based on the period’s average price. After the sale, the fund reported ...

Cincinnati, Ohio-based The Procter & Gamble Company (PG) is a consumer goods company that produces and markets a wide array of branded products across several categories, including beauty, grooming, healthcare, fabric & home care, and baby, feminine & family care. Valued at a market cap of $357 billion, the company’s portfolio includes globally recognized brands, including Tide, Ariel, Pampers, Gillette, Olay, Crest, and Pantene. It is expected to announce its fiscal Q1 earnings for 2026 before the market ...

Core Viewpoint - The Procter & Gamble Company is undergoing a significant restructuring and portfolio simplification to enhance growth amidst economic challenges and slowing sales [2][4]. Group 1: Restructuring and Job Cuts - The company plans to cut 7,000 jobs, approximately 6.4% of its global workforce, by mid-2027, focusing on non-manufacturing roles to improve productivity and resource allocation [2][4]. - This restructuring is in response to demands from activist investors for cost efficiency and a focus on core brands [2]. Group 2: Portfolio Streamlining - Procter & Gamble is streamlining its product lines, particularly in international markets, by reducing variety in certain categories and divesting slower-growing brands [3]. - The company is concentrating on core markets such as the U.S., China, Japan, Canada, and Western Europe, which show modest organic sales growth, while addressing underperforming "enterprise markets" [3]. Group 3: Financial Outlook - Analysts view Procter & Gamble as undervalued, with a 12-month price target of approximately $176, indicating a potential upside of 16% from current levels [4]. - Earnings per share (EPS) for fiscal 2026 is projected at $6.99, with stable revenue expected [4]. - The company's reputation for steady dividends and defensive characteristics makes it appealing in uncertain market conditions [4].

Core Insights - Procter & Gamble (P&G) announced a leadership change with COO Shailesh Jejurikar set to become the first Indian-American CEO starting January 1, 2026, succeeding Jon Moeller, who will transition to Executive Chairman [1][8][9] - The company reported a net sales figure of $84.284 billion for the fiscal year 2025, showing a slight increase from $84.039 billion in the previous year, with organic sales growth of 2% [2][4] - P&G's organic sales growth rate for fiscal year 2025 was the lowest in recent years, with a notable decline in the beauty segment, which saw a 2% drop in net sales [8][6] Financial Performance - For fiscal year 2025, P&G's net profit increased by 7% to approximately $16 billion, while gross profit remained relatively stable at $43.12 billion [2][3] - The company experienced a slight decrease in gross margin, down 0.2% to 51.2% [2] - The productivity plan announced in June aims to improve cost structure and competitiveness, with expected restructuring costs of $1 billion to $1.6 billion over the next two years [4][14] Segment Performance - The Fabric & Home Care segment generated net sales of $29.617 billion, remaining stable year-over-year, with a net profit increase of 3% to $5.848 billion [5][7] - The Beauty segment reported a 2% decline in net sales to $14.964 billion and an 8% drop in net profit to $2.715 billion [6][7] - The Health Care segment saw a 2% increase in net sales to $11.998 billion, with net profit rising by 8% to $2.440 billion [6][7] Market Trends - The Greater China region experienced a 5% decline in performance for fiscal year 2025, although there was a 2% growth in the most recent quarter [1][13] - P&G plans to raise prices on approximately 25% of its products in the U.S. due to tariff impacts, with an average price increase of about 2.5% across the portfolio [13][14] - The company anticipates a pre-tax cost increase of $1 billion due to tariffs, with specific impacts from imports from China and Canada [13][14]

Core Viewpoint - Procter & Gamble (P&G) has lowered its organic sales growth forecast for fiscal year 2025 from 3%-5% to 2% due to uncertainties surrounding U.S. tariffs, particularly affecting raw materials and packaging from China [1][6]. Financial Performance - For Q3 of fiscal year 2025, P&G reported a net sales decline of 2% year-over-year to $19.776 billion, with organic sales growth of 1% [2][3]. - The company's net profit slightly decreased from $3.754 billion to $3.769 billion [2]. - Product price increased by 1%, while sales volume decreased by 1% during the reporting period [3]. Business Segment Performance - Fabric & Home Care segment saw a 3% decline in net sales to $6.948 billion, with a 1% drop in net profit [2][3]. - Baby, Feminine & Family Care segment's net sales fell by 4% to $4.755 billion, with net profit down 12% [2][3]. - Beauty segment's net sales decreased by 2% to $3.490 billion, with an 8% decline in net profit [2][3]. - Health Care segment's net sales remained flat at $2.880 billion, while net profit increased by 8% [2][3]. - Grooming segment's net sales declined by 2% to $1.505 billion, with a 6% increase in net profit [2][3]. Regional Performance - In the Greater China region, organic sales fell by 2%, although SK-II experienced double-digit growth of 11% [4][5]. - The company noted that the Chinese market remains volatile, with a gradual recovery expected [5]. Tariff Impact and Strategic Response - The estimated annual cost impact of U.S. tariffs is between $1 billion to $1.5 billion, affecting profit margins by approximately 140 to 180 basis points [6]. - P&G plans to adopt more flexible procurement strategies, improve productivity, and consider innovative pricing methods to mitigate tariff impacts [6].

Core Insights - The article compares Procter & Gamble (PG) and Colgate-Palmolive (CL), highlighting their market positions, financial performance, and strategic priorities within the consumer-packaged goods (CPG) industry [1][2]. Procter & Gamble (PG) - PG operates in over 180 countries with a market capitalization close to $400 billion, offering a diverse product lineup including Tide, Pampers, Gillette, and Olay, which provides a competitive advantage [3]. - In Q3 fiscal 2025, PG reported earnings per share (EPS) of $1.54, meeting analyst expectations, while maintaining or growing market share in seven of its ten core categories [4]. - The company focuses on premiumization and innovation, launching high-performance products and investing in advertising rather than discount promotions, which supports long-term brand strength [5]. - PG anticipates approximately $200 million in after-tax headwinds from commodity costs and foreign exchange in fiscal 2025, alongside projected tariff-related costs of $1-$1.5 billion annually [6]. - The company plans to return $16-17 billion to shareholders through dividends and buybacks, demonstrating a commitment to long-term value creation [7]. Colgate-Palmolive (CL) - CL is a leader in oral care with a 41% share of the global toothpaste market and a 32% share in manual toothbrushes, while also expanding into pet nutrition and skincare [9][10]. - In Q1 2025, CL reported sales exceeding $4.91 billion, beating estimates despite a 3% year-over-year decline, with an EPS of 91 cents also surpassing expectations [11]. - The company expects $200 million in incremental tariff impacts in 2025 but is mitigating these through supply-chain flexibility and productivity gains, having invested $2 billion in U.S. supply-chain upgrades over the past five years [12]. - CL maintains a focus on advertising ROI and AI-driven analytics to optimize spending while continuing to innovate and premiumize its offerings [13]. - The company is positioned to deliver sustainable shareholder value through its strong balance sheet and disciplined execution, despite short-term pressures [14][26]. Financial Estimates - For fiscal 2025, PG's sales and EPS are expected to grow by 0.4% and 3%, respectively, with EPS estimates down by 1.2% in the past week [15]. - CL's sales and EPS estimates suggest year-over-year growth of 0.6% and 1.4%, with EPS estimates down by 0.5% recently [18]. - Both companies have experienced downward estimate revisions, but CL's revisions are less severe compared to PG [20]. Price Performance & Valuation - Year-to-date, PG shares have declined by 3.1%, while CL stock has gained 1.4% [21]. - PG is trading at a forward P/E multiple of 23.06X, below its five-year median of 23.65X, indicating a potentially undervalued position [23]. - CL's forward P/E multiple is at 24.47X, above its five-year median of 24.1X, reflecting its solid fundamentals and growth strategy [24]. Conclusion - PG's extensive global presence and diversified brand portfolio provide a foundation for long-term revenue stability, though it faces geopolitical and market-specific challenges [25]. - CL's strong brand equity and adaptability position it as an attractive investment option, particularly with lower tariff risks and solid fundamentals [27].

Core Viewpoint - Procter & Gamble's Q3 FY2025 results were characterized as moderate and below expectations, with net sales of $19.8 billion, a 2% decline year-over-year, and net profit of approximately $3.8 billion, remaining flat compared to the previous year [2] Group 1: Financial Performance - The company's Q3 sales fell short of analyst expectations, which were set at $20.11 billion, with market forecasts predicting only a 0.44% decline [2] - Organic sales, excluding foreign exchange, acquisitions, and divestitures, grew by 1% year-over-year [2] - The beauty and personal care segment saw slight growth, while sales in baby and feminine care products declined [2] Group 2: Pricing Strategy - Procter & Gamble's pricing strategy has partially offset the negative impact of declining sales, with an overall price increase of 1% in Q3 [2] - The company has a history of price increases, with the SK-II brand experiencing at least four price hikes since 2018, including a 12.5% increase in 2023 [2] - Management indicated that the company may implement further price increases starting in July for the new fiscal year [3] Group 3: Market Challenges - Despite the pricing strategy, the company faces challenges, as evidenced by a 2% sales decline in the Greater China region, which follows a 3% decline in the same period last year [5] - Management has expressed a commitment to reducing reliance on price increases for sales growth, but the complexity of current market conditions may necessitate continued price adjustments [4] - The company aims to focus on daily consumer goods and invest in innovations across different price points to enhance consumer value and drive category growth [6]